Slideshow
Author(s):
Atrial fibrillation recurrence remains a challenge amidst significant advances in managing stroke risk. Could the CHA2DS2-VASc score help?
Cardiology Month in Review: November 2024
Diabetes Dialogue: News and Updates in Diabetes at AHA 2024
FDA Accepts Alnylam’s sNDA for Vutrisiran for ATTR-CM
Kidney Compass: FLOW Insights from Kidney Week 2024, with Katherine Tuttle, MD
Muvalaplin, an Oral Lp(a)-Lowering Agent, Shows Promise in Phase 2 KRAKEN Trial
Zerlasiran 60-Week Data Reinforce Lp(a) Reductions Observed in ALPACAR-360